company background image
4194 logo

Holy Stone Healthcare TPEX:4194 Stock Report

Last Price

NT$12.10

Market Cap

NT$1.8b

7D

-4.0%

1Y

-37.8%

Updated

24 Dec, 2024

Data

Company Financials

Holy Stone Healthcare Co., Ltd.

TPEX:4194 Stock Report

Market Cap: NT$1.8b

My Notes

Capture your thoughts, links and company narrative

Holy Stone Healthcare Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Holy Stone Healthcare
Historical stock prices
Current Share PriceNT$12.10
52 Week HighNT$25.00
52 Week LowNT$11.95
Beta1.38
1 Month Change-18.24%
3 Month Change-30.86%
1 Year Change-37.82%
3 Year Change-58.27%
5 Year Change3.13%
Change since IPO-88.28%

Recent News & Updates

Recent updates

If You Had Bought Holy Stone Healthcare (GTSM:4194) Shares A Year Ago You'd Have Earned 108% Returns

Mar 20
If You Had Bought Holy Stone Healthcare (GTSM:4194) Shares A Year Ago You'd Have Earned 108% Returns

Holy Stone Healthcare (GTSM:4194) Is In A Strong Position To Grow Its Business

Jan 26
Holy Stone Healthcare (GTSM:4194) Is In A Strong Position To Grow Its Business

Announcing: Holy Stone Healthcare (GTSM:4194) Stock Increased An Energizing 193% In The Last Year

Dec 04
Announcing: Holy Stone Healthcare (GTSM:4194) Stock Increased An Energizing 193% In The Last Year

Shareholder Returns

4194TW BiotechsTW Market
7D-4.0%2.0%0.4%
1Y-37.8%1.6%28.7%

Return vs Industry: 4194 underperformed the TW Biotechs industry which returned 1.6% over the past year.

Return vs Market: 4194 underperformed the TW Market which returned 28.7% over the past year.

Price Volatility

Is 4194's price volatile compared to industry and market?
4194 volatility
4194 Average Weekly Movement5.5%
Biotechs Industry Average Movement4.5%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4194 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4194's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aAlbert Wuwww.hshc.com.tw

Holy Stone Healthcare Co., Ltd. develops therapeutics in Taiwan. It offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulcerative colitis; and GAF, a treatment for anal mucosal lesions. The company is also developing IBD98-M, which is in Phase IIa clinical trials for the treatment of inflammatory bowel diseases; and CA102N to treat colorectal cancer.

Holy Stone Healthcare Co., Ltd. Fundamentals Summary

How do Holy Stone Healthcare's earnings and revenue compare to its market cap?
4194 fundamental statistics
Market capNT$1.82b
Earnings (TTM)-NT$239.91m
Revenue (TTM)NT$222.29m

7.9x

P/S Ratio

-7.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4194 income statement (TTM)
RevenueNT$222.29m
Cost of RevenueNT$133.15m
Gross ProfitNT$89.15m
Other ExpensesNT$329.05m
Earnings-NT$239.91m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.64
Gross Margin40.10%
Net Profit Margin-107.93%
Debt/Equity Ratio0%

How did 4194 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:22
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Holy Stone Healthcare Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution